Dual-Stage Cognitive Assessment (DuCA)

1. Abstract

The Dual-Stage Cognitive Assessment (DuCA) is an evidence-based, sequential neuropsychological screening instrument developed by Cui et al. (2023) to optimize the early detection of neurocognitive disorders within high-throughput clinical environments, most notably primary care and community geriatric health centers. Recognizing the structural tension between brief screening tools (which often lack diagnostic sensitivity and domain granularity) and exhaustive neuropsychological batteries (which are prohibitively time-consuming for routine medical consultations), the DuCA operationalizes a tiered triage methodology. Part 1 operates as an ultra-rapid, 3-minute preliminary screen comprising verbal fluency, overlapping-figure visual perception, and episodic delayed recall (totaling 10 points). Patients demonstrating cognitive vulnerability or borderline performance proceed seamlessly to Part 2, a targeted secondary evaluation yielding 28 points across auditory sentence memory, executive category switching, and visual memory, culminating in a combined DuCA-total score of 38 points. Uniquely, the instrument embeds supplementary behavioral probes of prospective memory and subjective metamemory estimation, capturing subtle pre-clinical deficits without confounding normative scoring metrics.

Empirical validation in community-dwelling older adults—encompassing cognitively unimpaired individuals, patients with mild cognitive impairment (MCI), and individuals diagnosed with Alzheimer’s disease (AD)—demonstrates superior diagnostic accuracy. Receiver operating characteristic (ROC) analyses reveal that DuCA Part 1 achieves an Area Under the Curve (AUC) of 0.87 (95% CI: 0.848–0.883) for differentiating AD, matching the Addenbrooke’s Cognitive Examination III (ACE-III) (AUC = 0.86) and the Montreal Cognitive Assessment-Basic (MoCA-B) (AUC = 0.85). The comprehensive DuCA-total score yields an AUC of 0.93 (95% CI: 0.917–0.942) for AD, alongside robust discernment of amnestic MCI subtypes (AUC = 0.96 for combined auditory-visual memory impairment). Psychometric investigations establish high test-retest reproducibility (r = 0.95 over a 2-week interval), near-perfect inter-rater reliability (ICC = 0.98), and adequate internal consistency (standardized Cronbach’s alpha = 0.78 for DuCA-total), validating the instrument as an efficient, psychometrically sound paradigm for neurodegenerative disease surveillance.

2. Keywords

Dual-Stage Cognitive Assessment, DuCA, cognitive screening, mild cognitive impairment, Alzheimer’s disease, primary care neuropsychology, episodic memory, category switching, prospective memory, metamemory, psychometrics, geriatric assessment

3. Authors

The Dual-Stage Cognitive Assessment (DuCA) was designed and validated by an interdisciplinary team of clinical neuroscientists and geriatricians:

• Liang Cui, MD: Department of Gerontology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• Zhen Zhang, MD: Department of Gerontology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• Lin Huang, MD: Department of Gerontology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• Qinjie Li, MD: Department of Gerontology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• Yin-Han Guo, MBBS: Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
• Qi-Hao Guo, MD, PhD (Corresponding Author): Professor and Chief Physician, Department of Gerontology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai 200233, China. Email: [email protected].

4. Purpose

The primary clinical objective of the Dual-Stage Cognitive Assessment (DuCA) is to address the persistent diagnostic gap in primary healthcare settings regarding the early identification of neurodegenerative conditions, predominantly Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Epidemiological investigations consistently demonstrate that over 50% of community-dwelling older adults with clinically significant cognitive deterioration remain undiagnosed until advancing into moderate or severe dementia stages. This diagnostic delay largely stems from the pragmatic limitations of conventional neuropsychological batteries. Traditional screening instruments, such as the Mini-Mental State Examination (MMSE), exhibit notorious ceiling effects in highly educated individuals and demonstrate inadequate sensitivity for detecting subtle episodic and executive deficits characteristic of early amnestic MCI. Conversely, comprehensive assessment systems, such as the full Montreal Cognitive Assessment (MoCA) or the Addenbrooke’s Cognitive Examination III (ACE-III), require between 15 and 30 minutes to administer, rendering routine universal implementation impractical during standard 10-minute primary care consultations.

The DuCA resolves this workflow dilemma by adopting a standardized, conditionally branched two-stage architecture. The purpose of Stage 1 (DuCA Part 1) is to serve as an ultra-rapid triage filter. Requiring approximately three minutes of administration time, Part 1 extracts maximum discriminative variance by measuring three core cognitive functions that are pathologically vulnerable in early neurodegeneration: categorical semantic retrieval (verbal fluency), figure-ground visuoperceptual integration (overlapping figure identification), and verbal episodic retention (un-cued delayed recall). Individuals whose performance falls within expected normal thresholds can be cleared without unnecessary clinical burden, whereas those demonstrating borderline or failing performance are instantly triaged into Stage 2 (DuCA Part 2).

The second stage serves an in-depth diagnostic characterization purpose. It expands the neurocognitive inquiry across both auditory-verbal and visuospatial modalities, probing working memory span, multi-trial associative visual learning, cross-modal recognition, and complex executive control via alternated mental set shifting. Furthermore, the DuCA systematically integrates ecological probes of prospective memory (the capacity to execute delayed intentions) and metamemory (the cognitive appraisal of one’s own mnemonic capabilities). While these ecological probes do not alter the formal quantitative diagnostic score, they furnish general practitioners and neuropsychologists with qualitative markers of anosognosia and functional executive decay. Ultimately, the DuCA provides primary care clinicians with an empirically grounded instrument that harmonizes rapid screening efficiency with multi-domain diagnostic precision.

5. Psychological Construct

The Dual-Stage Cognitive Assessment evaluates human cognitive architecture through an integrated, multi-system psychometric paradigm. Rather than treating cognition as a unitary global entity, the DuCA operationalizes distinct, neuropsychologically validated constructs that map directly onto localized cortical and subcortical functional networks.

1. Semantic Retrieval and Lexical Access

Evaluated through timed category generation (semantic verbal fluency), this construct reflects the integrity of semantic memory storage within the lateral temporal cortex, in conjunction with executive retrieval strategies coordinated by the left inferior prefrontal cortex. The requirement to rapidly search, access, and articulate category exemplars within a fixed temporal window (60 seconds) gauges both processing speed and the systematic activation of semantic networks. In neurodegenerative pathology, early depletion of semantic hubs causes marked reductions in cluster sizing and lexical switching efficiency.

2. Visuoperceptual Figure-Ground Integration

Assessed through the identification of overlapped contour line drawings, this construct captures high-order visual processing and perceptual closure. It relies heavily on the ventral visual stream (“what pathway”) extending from the primary visual cortex to the inferior temporal lobes, alongside parietal attentional networks. Deficits in disentangling overlapping objects reflect early visual agnosia, visual perceptual fragmentation, and simultaneous agnosia, which frequently occur in posterior cortical atrophy and typical amnestic presentations of Alzheimer’s disease.

3. Multi-Trial and Multi-Modal Episodic Memory

Episodic memory forms the core construct of the DuCA, operationalized across verbal, auditory, and visual channels:

• Verbal Episodic Memory: Measured via immediate registration, multi-trial presentation, and un-cued delayed free recall of a five-word lexical array. This construct reflects medial temporal lobe integrity, specifically hippocampal consolidation and entorhinal encoding mechanisms.
• Auditory Sentence Memory: Probes verbal working memory storage, syntactic parsing, and immediate auditory-verbal retention. It engages the phonological loop within Baddeley’s multicomponent working memory model, supported by the left perisylvian and superior temporal regions.
• Visual Associative and Recognition Memory: Evaluated through multi-trial visual confrontation encoding, immediate recall, delayed free recall, and cued recognition of pictorial stimuli. By comparing free retrieval against cued recognition performance, the construct enables clinicians to dissociate primary encoding/storage failure (typical of hippocampal damage) from retrieval-access deficits (typical of frontal-subcortical vascular pathology).

4. Cognitive Flexibility and Executive Shifting

Operationalized through the Category Switching Test, this construct measures the central executive’s capacity to maintain two distinct semantic rules simultaneously in working memory while executing continuous mental set-shifting (alternating between animal and fruit taxonomies). Set-shifting requires dynamic suppression of cognitive inertia, proactive response inhibition, and intact dorsolateral prefrontal cortex (DLPFC) signaling coupled with striatal-thalamic circuits.

5. Prospective Memory and Metacognitive Monitoring

The DuCA incorporates two vital ecological constructs:

• Time- and Event-Based Prospective Memory: Evaluates the delayed execution of an intended action (drawing a geometric shape and signing one’s name upon test termination) without explicit concurrent prompting. This engages rostral prefrontal cortex (Brodmann Area 10) networks mediating intentionality and self-initiated retrieval.
• Metamemory (Mnemonic Calibration): Probed by prompting examinees to quantitatively predict their delayed retrieval yields prior to recall. Metacognitive monitoring captures the discrepancy between self-appraisal and objective performance, serving as an index of self-awareness and frontal monitoring integrity.

6. Theoretical Framework

The theoretical architecture of the Dual-Stage Cognitive Assessment is anchored in three convergent paradigms within modern cognitive science: the multicomponent model of working memory, neurocognitive models of episodic memory consolidation, and two-stage sequential clinical decision theory.

The Baddeley Mnemonic Framework

Alan Baddeley’s structural model posits that working memory consists of an attentional supervisory system (the central executive) directing two modality-specific slave subsystems: the phonological loop (handling acoustic and verbal information) and the visuospatial sketchpad (handling visual imagery and spatial coordinate processing). The DuCA is explicitly architected around this modality-specific divergence. In early neurodegenerative syndromes, pathological tau phosphorylation and beta-amyloid deposition do not affect phonological and visuospatial pathways symmetrically. By structuring Part 2 into separate auditory sentence memory and multi-trial pictorial visual memory subtests, the DuCA operationalizes Baddeley’s theoretical model to diagnose isolated auditory-amnestic MCI (MCI-A), visual-amnestic MCI (MCI-V), or dual-modality amnestic impairment (MCI-AV).

Neurocognitive Consolidation and Retrieval Dissociation

The scale integrates the foundational consolidation theories formulated by Larry Squire and Endel Tulving. According to Tulving’s episodic memory taxonomy, retrieval relies upon a distinct subjective state of conscious re-experience (“autonoetic consciousness”). In clinical assessment, distinguishing between failure of consolidation (hippocampal storage degradation) and failure of retrieval search strategies (frontal executive dysregulation) is clinically paramount. The DuCA embeds a three-tier mnemonic hierarchy: immediate acquisition trials, delayed spontaneous free recall, and forced-choice cued recognition. When a patient demonstrates poor free recall but normalizes under cued recognition conditions, the theoretical inference points to frontal-subcortical retrieval deficits rather than primary hippocampal amnesia, significantly refining differential diagnosis between Alzheimer-type pathology and vascular cognitive impairment.

Sequential Decision and Triage Theory

From an applied psychometric perspective, the DuCA operationalizes Wald’s sequential probability ratio theory within clinical screening. Universal administration of extensive cognitive test batteries incurs high institutional costs and induces cognitive fatigue in frail elderly individuals, which paradoxically inflates false-positive rates due to waning sustained attention. By bifurcating the assessment into an ultra-brief pre-test probability filter (Stage 1) followed by an enriched diagnostic battery (Stage 2), the DuCA optimizes Bayesian diagnostic likelihood ratios. Stage 1 maximizes negative predictive value to rapidly rule out unimpaired individuals, while Stage 2 elevates positive predictive specificity, maximizing diagnostic yield while preserving clinical bandwidth.

7. Validity

The psychometric validity of the Dual-Stage Cognitive Assessment was rigorously evaluated in an empirical cohort study conducted by Cui et al. (2023), involving older adult participants categorized into cognitively unimpaired controls, patients with mild cognitive impairment (MCI), and individuals with clinically diagnosed Alzheimer’s disease (AD).

Discriminant and Criterion-Related Validity

The primary index of diagnostic discriminability was established using Receiver Operating Characteristic (ROC) curve analysis. For differentiating individuals with Alzheimer’s disease from cognitively healthy controls, the 3-minute Stage 1 screener (DuCA Part 1) achieved an Area Under the Curve (AUC) of 0.87 (95% CI: 0.848–0.883). This discriminative performance matched or exceeded long-form international standards administered within the same demographic context, including the Addenbrooke’s Cognitive Examination III (ACE-III; AUC = 0.86, 95% CI: 0.838–0.874) and the Montreal Cognitive Assessment-Basic (MoCA-B; AUC = 0.85, 95% CI: 0.830–0.868).

When the full instrument was administered, the DuCA-total score demonstrated superior discriminant validity for Alzheimer’s disease, yielding an overall AUC of 0.93 (95% CI: 0.917–0.942). At the optimal diagnostic cut-off score of ≤ 15 points (out of 38), the DuCA-total attained an exceptional sensitivity of 98.5% paired with a specificity of 80.0%. When adjusting the cut-off threshold to a more conservative ≤ 13 points, the sensitivity remained robust at 85.5% while specificity increased to 90.8%, confirming the scale’s clinical flexibility depending on whether the screening priority is universal case-finding or minimizing false-positive referrals.

Subtype Sensitivity in Mild Cognitive Impairment

A notable validation achievement of the DuCA is its empirical efficacy in identifying heterogeneous presentations of MCI. The DuCA-total proved exceptionally sensitive to subtle, modality-specific amnestic impairments:

• Auditory-impaired MCI (MCI-A): DuCA-total demonstrated an AUC of 0.89 (95% CI: 0.871–0.913).
• Combined Auditory- and Visual-impaired MCI (MCI-AV): DuCA-total yielded an outstanding AUC of 0.96 (95% CI: 0.951–0.970).
• Other Subtypes of MCI: DuCA-total sustained an AUC of 0.91 (95% CI: 0.879–0.937).

These findings confirm that the inclusion of dual-modality mnemonic paradigms in Stage 2 confers significantly higher criterion-related validity than conventional single-modality verbal screening batteries.

8. Reliability

The measurement precision, stability, and observer consistency of the Dual-Stage Cognitive Assessment have been confirmed through rigorous classical test theory (CTT) metrics.

Internal Consistency

Reliability analysis conducted by Cui et al. (2023) revealed a standardized Cronbach’s alpha of 0.56 for the isolated DuCA Part 1 screener. This modest coefficient is expected and psychometrically appropriate for an ultra-brief triage tool consisting of only three disparate, orthogonal cognitive tasks (verbal generation, visual perceptual discrimination, and verbal recall). Brief screening subscales measuring fundamentally distinct neuroanatomical domains deliberately trade off high internal item redundancy to capture broad domain coverage without variance inflation. When the complete instrument was evaluated, the DuCA-total exhibited a standardized Cronbach’s alpha of 0.78, indicating adequate internal consistency and homogeneous construct convergence across the multi-domain composite score.

Inter-Rater Reliability

Because cognitive instruments rely on manual scoring of spoken and drawn responses, inter-examiner reproducibility is vital. The inter-rater reliability for the DuCA-total score was documented at an exceptional intraclass correlation coefficient (ICC) of 0.98. This high degree of scoring concordance is attributable to the standardized, unambiguous scoring rubrics provided for each task, such as absolute categorical counts for verbal fluency and clear visual boundary criteria for the overlapping-figures test.

Test-Retest Stability

Temporal stability was established by re-administering the DuCA to a subsample of community-dwelling participants after an exact two-week interval. The test-retest consistency coefficient for the DuCA-total score was r = 0.95, establishing outstanding temporal reliability. This confirms that the DuCA possesses negligible measurement noise and is stable for longitudinal clinical tracking, disease progression monitoring, and pharmacological treatment evaluation in geriatric populations.

9. Factor Analysis

In the primary psychometric development publication of the DuCA (Cui et al., 2023), formal exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were not reported. The structural composition of the battery was derived primarily through rational-theoretical task construction and criterion-referenced clinical utility, rather than data-driven latent item reduction.

From a theoretical psychometric standpoint, the DuCA’s architecture reflects a distinct multi-dimensional latent structure. If modeled under a structural equation framework, the battery would be best conceptualized as a bifactor or higher-order hierarchical model. Under this paradigm, a general global cognitive factor (g-cognition) accounts for shared variance across all tasks, while three primary orthogonal domain factors capture specific cognitive processes:

• Domain Factor 1: Episodic Mnemonic Processing (subsuming verbal delayed free recall, visual immediate recall, visual delayed free recall, visual recognition, and auditory sentence delayed recall).
• Domain Factor 2: Executive Function and Attentional Set-Shifting (subsuming semantic verbal fluency, the Category Switching Test, and the delayed execution of prospective memory intentions).
• Domain Factor 3: Visuoperceptual and Spatial Discrimination (subsuming the overlapping figures perceptual integration subtest).

The deliberate inclusion of non-scored auxiliary items (metamemory estimation and prospective memory performance) further supports the multifaceted clinical architecture of the tool. Future psychometric investigations utilizing larger, culturally diverse cohorts will benefit from conducting formal CFA to verify item-to-factor loadings, compute structural fit indices (such as RMSEA, CFI, and TLI), and evaluate measurement invariance across different educational tiers and age brackets.

10. Instrument / Measurement Tool

The Dual-Stage Cognitive Assessment is an examiner-administered clinical screening battery consisting of two sequential phases, spanning a total quantitative score of 38 points, alongside qualitative behavioral indices.

Structural Configuration

• Test Type: Performance-based neurocognitive screening instrument.
• Administration Format: Paper-and-pencil examiner-administered interview and visual presentation.
• Target Population: Adults aged 18 years and older; optimized for middle-aged and older adults (aged 40 to 85+ years) suspected of MCI or early dementia.
• Administration Time:
  • Part 1 (Rapid Triage): Approximately 3 minutes.
  • Part 2 (Secondary Assessment): Approximately 10 to 12 minutes.
  • Total Combined Battery: Approximately 15 minutes.
• Scoring Architecture: Total maximal score is 38 points, derived from:
  • Part 1 Total: 10 points.
  • Part 2 Total: 28 points.
  • Supplementary Unscored Items: Prospective Memory and Metamemory (recorded for qualitative/clinical judgment).

Subtest Scoring Rules

• Part 1: Verbal Fluency (Max: 2 points)
  • > 13 correct fruits named in 60 seconds = 2 points.
  • 8 to 12 correct fruits named = 1 point.
  • ≤ 7 correct fruits named = 0 points.
• Part 1: Visual Perception (Max: 3 points)
  • Identification of 10 overlapping objects (scissors, cup, t-shirt, watch, banana, leaf, table lamp, key, candle, spoon).
  • 9–10 objects correctly identified = 3 points.
  • 6–8 objects correctly identified = 2 points.
  • 4–5 objects correctly identified = 1 point.
  • ≤ 3 objects correctly identified = 0 points.
• Part 1: Delayed Free Recall (Max: 5 points)
  • Spontaneous, un-cued retrieval of the 5 registered target words (Rose, Foot, Sofa, Blue, Knife). 1 point per correctly recalled word.
• Part 2: Auditory Sentence Memory (Max: 6 points)
  • Accurate verbal repetition and recall of sentence components. 1 point per accurate item; maximum ceiling of 6 points for ≥ 6 items.
• Part 2: Category Switching Test (Max: 10 points)
  • Continuous verbal alternation between animal and fruit categories in 60 seconds (e.g., dog, apple, horse, orange). Each correctly alternated exemplar receives 0.5 points (maximum 10 points for 20 correct alternating items).
• Part 2: Visual Memory (Max: 12 points)
  • Calculated using the standardized clinical composite formula: (Visual Immediate Recall 2 score + Visual Delayed Free Recall score) ÷ 2.

Clinical Interpretation Cut-Off Scores (DuCA-Total / 38)

• Score ≤ 15: High-sensitivity threshold for neurocognitive impairment / Alzheimer’s disease (Sensitivity = 98.5%, Specificity = 80.0%). Highly recommended for broad community triage.
• Score ≤ 13: High-specificity threshold for neurocognitive impairment / Alzheimer’s disease (Sensitivity = 85.5%, Specificity = 90.8%). Recommended when avoiding false positives is critical prior to secondary neuroimaging or CSF biomarker referrals.

11. Permissions & Fee and Test Year

• Year of Initial Publication: 2023.
• Original Authors: Liang Cui, Zhen Zhang, Lin Huang, Qinjie Li, Yin-Han Guo, and Qi-Hao Guo.
• Publishing Journal: BMC Psychiatry (BioMed Central / Springer Nature).
• Licensing and Copyright: The DuCA is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this open-access framework, clinicians, researchers, and academic institutions may reproduce, distribute, adapt, and build upon the instrument freely without paying royalties or licensing fees.
• Commercial Usage: Unrestricted non-commercial and academic usage is permitted, provided appropriate attribution is given to the original authors and the initial publication venue. Commercial distribution or integration into proprietary software requires alignment with CC BY 4.0 attribution terms and potential institutional coordination with Shanghai Sixth People’s Hospital.
• Contact for Permissions & Inquiries: Qi-Hao Guo, Department of Gerontology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China (Email: [email protected]).

12. References

• Baddeley, A. (2000). The episodic buffer: A new component of working memory? Trends in Cognitive Sciences, 4(11), 417–423. https://doi.org/10.1016/s1364-6613(00)01538-2
• Cui, L., Zhang, Z., Huang, L., Li, Q., Guo, Y.-H., & Guo, Q.-H. (2023). Dual-stage cognitive assessment: A two-stage screening for cognitive impairment in primary care. BMC Psychiatry, 23(1), Article 368. https://doi.org/10.1186/s12888-023-04883-w
• Huang, L., Chen, K. L., Lin, B. X., Tang, L., Zhao, Q. H., Lv, Y. R., Dong, Y., & Guo, Q. H. (2018). Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease. Neuropsychiatric Disease and Treatment, 14, 2133–2140. https://doi.org/10.2147/NDT.S174293
• Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
• Pan, D., Lin, B., Xiao, F., Chen, S., & Guo, Q. (2022). Reliability and validity of the Chinese version of Addenbrooke’s Cognitive Examination III for cognitive impairment screening in elderly people. Frontiers in Aging Neuroscience, 14, Article 821946. https://doi.org/10.3389/fnagi.2022.821946
• Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303–308. https://doi.org/10.1001/archneur.56.3.303
• Squire, L. R., & Zola, S. M. (1996). Structure and function of declarative and nondeclarative memory systems. Proceedings of the National Academy of Sciences, 93(24), 13515–13522. https://doi.org/10.1073/pnas.93.24.13515

13. Items of the Scale